Macrophage Activation Syndrome
What's New
Last Posted: Jul 05, 2024
- Enrichment of Rare Variants of Hemophagocytic Lymphohistiocytosis Genes in Systemic Juvenile Idiopathic Arthritis.
Mariana Correia Marques, et al. Arthritis & rheumatology (Hoboken, N.J.) 2024 0 - Early identification of macrophage activation syndrome secondary to systemic lupus erythematosus with machine learning.
Wenxun Lin et al. Arthritis Res Ther 2024 26(1) 92 - Adults with septic shock and extreme hyperferritinemia exhibit pathogenic immune variation.
Kernan Kate F, et al. Genes and immunity 2018 0 (6) 520-526 - Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis.
Eloseily Esraa M, et al. Arthritis & rheumatology (Hoboken, N.J.) 2019 0 (2) 326-334 - Emergent high fatality lung disease in systemic juvenile arthritis.
Saper Vivian E, et al. Annals of the rheumatic diseases 2019 0 (12) 1722-1731 - Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp Wesley Tyler, et al. JAMA cardiology 2020 0 (10) 1170-1175 - The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.
Bami Sakshi, et al. Pediatric blood & cancer 2020 0 (11) e28581 - Recessive NLRC4-Autoinflammatory Disease Reveals an Ulcerative Colitis Locus.
Steiner Annemarie, et al. Journal of clinical immunology 2021 0 (2) 325-335 - Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles.
Saper Vivian E, et al. Annals of the rheumatic diseases 2021 0 (3) 406-415 - Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19.
Kerget Ferhan, et al. Journal of medical virology 2021 0 (12) 6653-6659
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: